Skip to main content

fidaxomicin

Generic: FIDAXOMICIN·Brand: DIFICID, Dificid, FIDAXOMICIN

fidaxomicin: 2 clinical trials tracked.

fidaxomicin evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about fidaxomicin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 1 study sponsors

Related indications

No linked indication is available.

Clinical Trials (2)

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides Difficile Infection 2: A Randomized Controlled Trial

NCT07328971·Phase 3
Recruiting

Primary endpoint: CDI Recurrence

InterventionalRandomizedsingle500 targetStarted 2026-04Completion 2030-111 site · CanadaMcGill University Health Centre/Research Institute of the McGill University Health Centre

A Phase II, Randomized, Open-Label, Active-Controlled Clinical Study to Investigate the Safety and Efficacy of SMT19969 (200mg BID) for 10 Days Compared With Fidaxomicin (200 mg BID) for 10 Days for the Treatment of Clostridium Difficile Infection (CDI)

NCT02784002·Phase 2·SMMT
Completed

Primary endpoint: Number of treatment emergent adverse events (AEs) and serious adverse events (SAEs) to evaluate safety and tolerability

InterventionalRandomizedopen27 enrolledStarted 2014-12Completion 2016-0816 sites · Czechia, United Kingdom, United StatesSummit Therapeutics